Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNDT
276
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $22.6M | 0.01% |
1,269,234
+794
| +0.1% | +$15.1K |
|
277
Merit Medical Systems
MMSI
$5.24B
| $22.6M | 0.01% |
314,257
+35,745
| +13% | +$2.43M |
|
278
UMB Financial
UMBF
$11B
| $22.4M | 0.01% |
231,993
-10,792
| -4% | -$984K |
|
279
Cheesecake Factory
CAKE
$5.34B
| $22.3M | 0.01% |
474,789
-11,003
| -2% | -$517K |
|
280
EOG Resources
EOG
$71.4B
| $21.9M | 0.01% |
273,072
+16,149
| +6% | +$1.18M |
|
281
Veeco
VECO
$3.15B
| $21.1M | 0.01% |
951,985
-23,977
| -2% | -$534K |
|
282
Cognyte Software
CGNT
$667M
| $21.1M | 0.01% |
1,024,520
-25,538
| -2% | -$653K |
|
|
ZEN
283
DELISTED
ZENDESK INC
ZEN
| $21M | 0.01% |
180,124
+15,108
| +9% | +$1.95M |
|
284
Diodes
DIOD
$4.54B
| $20.4M | 0.01% |
225,182
-159
| -0.1% | -$13.9K |
|
285
D.R. Horton
DHI
$40.8B
| $20M | 0.01% |
238,588
+17,981
| +8% | +$1.66M |
|
286
AAR Corp
AIR
$5.89B
| $20M | 0.01% |
616,585
-14,959
| -2% | -$515K |
|
287
Kaiser Aluminum
KALU
$2.8B
| $19.6M | 0.01% |
179,910
+1,113
| +0.6% | +$133K |
|
288
Delek US
DK
$3.6B
| $19.2M | 0.01% |
1,069,443
-431,876
| -29% | -$7.36M |
|
289
Occidental Petroleum
OXY
$55.7B
| $19.2M | 0.01% |
649,154
-26,137
| -4% | -$698K |
|
290
KraneShares CSI China Internet ETF
KWEB
$5.62B
| $18.7M | 0.01% |
395,528
+54,435
| +16% | +$2.86M |
|
291
Carpenter Technology
CRS
$27.7B
| $18.6M | 0.01% |
568,926
-9
| -0% | -$319 |
|
292
Prosperity Bancshares
PB
$8.88B
| $18.1M | 0.01% |
253,883
-5,356
| -2% | -$371K |
|
|
TPH
293
DELISTED
Tri Pointe Homes
TPH
| $17.9M | 0.01% |
849,743
-28,829
| -3% | -$650K |
|
|
ARNC
294
DELISTED
Arconic Corporation
ARNC
| $17.7M | 0.01% |
562,466
-17,954
| -3% | -$613K |
|
295
Teradyne
TER
$60.2B
| $17.7M | 0.01% |
162,120
-249
| -0.2% | -$30.3K |
|
296
Viavi Solutions
VIAV
$10B
| $17.7M | 0.01% |
1,121,957
+68,646
| +7% | +$1.13M |
|
297
AeroVironment
AVAV
$8.66B
| $17.6M | 0.01% |
204,448
+7,857
| +4% | +$760K |
|
298
Core Laboratories
CLB
$513M
| $16.5M | 0.01% |
596,358
-163,674
| -22% | -$4.98M |
|
|
X
299
DELISTED
US Steel
X
| $16.5M | 0.01% |
750,451
-26,477
| -3% | -$662K |
|
300
iShares Core MSCI Europe ETF
IEUR
$9.08B
| $16.5M | 0.01% |
293,828
-14,971
| -5% | -$873K |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.